FDA warning letter
Issue date
19 Jun 2020
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
7 Jul 2020
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Washington Homeopathic Products
Warning letter
Headquarters
United States of America